跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Tri-Alzor - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Tri-Alzor
Approved
STANDARD
Tri-Alzor
Ajanta Pharma Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
0b66f91787a09e09
Company
Ajanta Pharma Limited
Type
Standard
Approval Details
Approval Id
0b66f91787a09e09
Drug Approval Philippines Name
Tri-Alzor
Product Name
Tri-Alzor
Registration Number
DR-XY38890
Brand Name
Tri-Alzor
Generic Name
Olmesartan medoxomil + Amlodipine (as besilate) + Hydrochlorothiazide
Dosage Form
Film-Coated Tablet
Dosage Strength
20 mg/5 mg/12.5 mg
Manufacturer
Ajanta Pharma Limited
Company Detail Path
/organization/ajanta-pharma-limited
Issuance Date
26 May 2022
Expiry Date
23 December 2025
Pharmacologic Category
Angiotensin II Receptor Blocker Combination
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
0b66f91787a09e09
Type
Standard
Back to Philippines FDA Approvals